AIP
Arteris, Inc.
$35.28
+0.94%
$1.6B
No data for this timeframe.
Vol
Market Cap$1.6B
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (75%)
Inst. Holders7 funds
Inst. Value$37.4M
Inst. Activity2 buys / 2 sells
Insider Activity0B / 37S
Insider Net $-$21.0M
Reddit Sentiment50° Neutral
SEC Reports14
Recent Activity
May 20, 2026
SEC
Two insiders at Arteris sold a total of $2.51M in open-market sales within a week of the company's strong Q1 earnings be
CLUSTER — Impact 4/10
May 20, 2026
other
Arteris Technology Adopted by Li Auto for Intelligent Vehicles
Arteris technology adopted by Li Auto for intelligent vehicles, starting with its proprietary SoCs u
May 18, 2026
Insider
JANAC K CHARLES sold 50,000 shares
President and CEO @ $0.00 ($0.00)
May 18, 2026
Insider
Bayview Legacy, LLC sold 50,000 shares
10%+ Owner @ $0.00 ($0.00)
May 16, 2026
SEC
Insiders at Arteris, including CEO and CFO, sold a total of $6.87M in shares over the past week, following a strong Q1 e
CLUSTER — Impact 4/10
May 15, 2026
SEC
Nicholas B. Hawkins, an officer of Arteris, filed a Form 144 to sell 221,035 shares of common stock with an estimated ag
144 — Impact 5/10
May 15, 2026
Insider
Hawkins Nicholas B. sold 197,396 shares
VP and Chief Financial Officer @ $0.5600 ($110.5K)
Inst.
MORGAN STANLEY — TRIM
244,695 shares ($3.8M)
Price Targets
$37.75
+7.0% upside
Buy
Current $35.28
Low $35.00
Median $38.00
High $40.00
4 analysts
$35.00
$40.00
Analyst Ratings
1Strong Buy
5Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 13, 2026 | Jefferies | MAINTAIN | Hold → Hold |
| May 13, 2026 | TD Cowen | MAINTAIN | Buy → Buy |
| May 13, 2026 | Rosenblatt | MAINTAIN | Buy → Buy |
| Feb 13, 2026 | Rosenblatt | MAINTAIN | Buy → Buy |
| Dec 15, 2025 | Rosenblatt | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.04 | $-0.05 — $-0.03 | 66% YoY | 4 |
| Next Q | $-0.02 | $-0.03 — $-0.02 | 75% YoY | 4 |
| Current FY | $-0.09 | $-0.10 — $-0.07 | 73% YoY | 4 |
| Next FY | $0.16 | $0.13 — $0.20 | 283% YoY | 3 |
Latest Reports
NEUTRAL
CLUSTER
4/10
Two insiders at Arteris sold a total of $2.51M in open-market sales within a week of the company's strong Q1 earnings be
May 20, 2026
NEUTRAL
CLUSTER
4/10
Insiders at Arteris, including CEO and CFO, sold a total of $6.87M in shares over the past week, following a strong Q1 e
May 16, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $28.7M | — |
| MORGAN STANLEY | $3.8M | TRIM |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $1.5M | NEW |
| RENAISSANCE TECHNOLOGIES LLC | $1.4M | TRIM |
| BANK OF AMERICA CORP | $862.5K | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 18, 2026 | JANAC K | G | $0.00 |
| May 18, 2026 | Bayview Legacy, | G | $0.00 |
| May 15, 2026 | Hawkins Nicholas | M | $110.5K |
| May 15, 2026 | Hawkins Nicholas | SELL | $1.7M |
| May 15, 2026 | Hawkins Nicholas | M | $0.00 |
Reddit Sentiment
50°▲
Neutral
Bearish
Neutral
Bullish
7 institutional holders with $37.4M total value (2,415,169 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, CHARLES.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 1,852,669 | $28.7M | 76.7% | — |
| 2 | MORGAN STANLEY | 244,695 | $3.8M | 10.1% | TRIM -36.0% |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 94,888 | $1.5M | 3.9% | NEW |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 88,700 | $1.4M | 3.7% | TRIM -51.7% |
| 5 | BANK OF AMERICA CORP /DE/ | 55,643 | $862.5K | 2.3% | ADD +69.0% |
| 6 | FMR LLC | 41,912 | $649.6K | 1.7% | ADD +80.2% |
| 7 | WELLS FARGO & COMPANY/MN | 36,662 | $568.3K | 1.5% | ADD +45.6% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | TRIM | 382,412 | 244,695 | -36.0% | $3.8M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 183,800 | 88,700 | -51.7% | $1.4M | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 32,919 | 55,643 | +69.0% | $862.5K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 25,186 | 36,662 | +45.6% | $568.3K | 2025-Q4 |
| UBS Group AG | ADD | 51,271 | 92,716 | +80.8% | $936.4K | 2025-Q3 |
| FMR LLC | ADD | 21,758 | 39,210 | +80.2% | $396.0K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 57,093 | 32,919 | -42.3% | $332.5K | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | ADD | 19,770 | 25,186 | +27.4% | $254.4K | 2025-Q3 |
| MORGAN STANLEY | DOUBLED | 129,466 | 374,723 | +189.4% | $3.6M | 2025-Q2 |
| UBS Group AG | ADD | 28,482 | 51,271 | +80.0% | $488.6K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | ADD | 13,805 | 19,770 | +43.2% | $188.4K | 2025-Q2 |
| MORGAN STANLEY | ADD | 99,798 | 129,466 | +29.7% | $894.6K | 2025-Q1 |
| UBS Group AG | TRIM | 93,301 | 28,482 | -69.5% | $196.8K | 2025-Q1 |
| FMR LLC | DOUBLED | 823 | 21,394 | +2499.5% | $147.8K | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 55,017 | 21,000 | -61.8% | $145.1K | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 60,533 | 0 | -100.0% | $0.00 | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 142,000 | 183,865 | +29.5% | $1.9M | 2024-Q4 |
| UBS Group AG | DOUBLED | 13,024 | 93,301 | +616.4% | $950.7K | 2024-Q4 |
| CITADEL ADVISORS LLC | ADD | 28,200 | 55,017 | +95.1% | $560.6K | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 9,498 | 13,192 | +38.9% | $134.4K | 2024-Q4 |
| MORGAN STANLEY | ADD | 55,719 | 104,092 | +86.8% | $803.6K | 2024-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 75,392 | — | $582.0K | 2024-Q3 |
10 unique insiders with 37 transactions. Net insider value: -$21.0M ($0.00 bought, $21.0M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 18, 2026 | JANAC K CHARLES | President and CEO | G | 50,000 | $0.00 | $0.00 |
| May 18, 2026 | Bayview Legacy, LLC | 10%+ Owner | G | 50,000 | $0.00 | $0.00 |
| May 15, 2026 | Hawkins Nicholas B. | VP and Chief Financial Officer | M | 197,396 | $0.5600 | $110.5K |
| May 15, 2026 | Hawkins Nicholas B. | VP and Chief Financial Officer | SELL | 52,928 | $32.97 | $1.7M |
| May 15, 2026 | Hawkins Nicholas B. | VP and Chief Financial Officer | M | 197,396 | $0.00 | $0.00 |
| May 15, 2026 | Hawkins Nicholas B. | VP and Chief Financial Officer | M | 15,625 | $0.00 | $0.00 |
| May 14, 2026 | Viana Antonio J | Director | SELL | 20,000 | $38.00 | $760.0K |
| May 13, 2026 | Viana Antonio J | Director | SELL | 15,538 | $34.06 | $529.2K |
| May 8, 2026 | JANAC K CHARLES | President and CEO | SELL | 70,000 | $31.20 | $2.2M |
| May 8, 2026 | Bayview Legacy, LLC | 10%+ Owner | SELL | 70,000 | $31.20 | $2.2M |
| May 5, 2026 | Viana Antonio J | Director | SELL | 20,000 | $30.07 | $601.5K |
| May 5, 2026 | Chitkara Raman | Director | SELL | 5,000 | $30.05 | $150.3K |
| Apr 24, 2026 | Viana Antonio J | Director | SELL | 20,000 | $26.11 | $522.2K |
| Apr 24, 2026 | Chitkara Raman | Director | SELL | 5,000 | $25.06 | $125.3K |
| Apr 20, 2026 | RAZA SAIYED ATIQ | Director | SELL | 17,060 | $22.16 | $378.1K |
| Apr 17, 2026 | Viana Antonio J | Director | SELL | 20,000 | $22.11 | $442.2K |
| Apr 17, 2026 | RAZA SAIYED ATIQ | Director | SELL | 72,940 | $22.16 | $1.6M |
| Apr 14, 2026 | Chitkara Raman | Director | SELL | 5,000 | $20.05 | $100.3K |
| Apr 14, 2026 | Moll Laurent R | Chief Operating Officer | SELL | 13,448 | $20.03 | $269.4K |
| Apr 13, 2026 | Moll Laurent R | Chief Operating Officer | SELL | 1,003 | $19.90 | $20.0K |
| Apr 10, 2026 | Moll Laurent R | Chief Operating Officer | SELL | 990 | $19.90 | $19.7K |
| Apr 8, 2026 | Bayview Legacy, LLC | 10%+ Owner | SELL | 70,000 | $19.04 | $1.3M |
| Apr 8, 2026 | JANAC K CHARLES | President and CEO | SELL | 70,000 | $19.04 | $1.3M |
| Apr 6, 2026 | Moll Laurent R | Chief Operating Officer | SELL | 1,552 | $18.23 | $28.3K |
| Apr 6, 2026 | JANAC K CHARLES | President and CEO | SELL | 11,800 | $18.34 | $216.4K |
| Apr 5, 2026 | Kunkel Joachim | Director | A | 899 | $0.00 | $0.00 |
| Apr 5, 2026 | Munce Claudia F. | Director | A | 860 | $0.00 | $0.00 |
| Apr 2, 2026 | Hawkins Nicholas B. | VP and Chief Financial Officer | SELL | 1,491 | $17.65 | $26.3K |
| Apr 2, 2026 | Moll Laurent R | Chief Operating Officer | SELL | 888 | $17.65 | $15.7K |
| Apr 2, 2026 | JANAC K CHARLES | President and CEO | SELL | 1,618 | $17.65 | $28.6K |
| Apr 2, 2026 | Alpern Paul L | VP and General Counsel | SELL | 766 | $17.65 | $13.5K |
| Mar 26, 2026 | Bayview Legacy, LLC | 10%+ Owner | SELL | 32,988 | $18.35 | $605.2K |
| Mar 26, 2026 | JANAC K CHARLES | President and CEO | SELL | 32,988 | $18.35 | $605.2K |
| Mar 25, 2026 | Bayview Legacy, LLC | 10%+ Owner | SELL | 7,012 | $18.03 | $126.4K |
| Mar 25, 2026 | JANAC K CHARLES | President and CEO | SELL | 7,012 | $18.03 | $126.4K |
| Mar 10, 2026 | JANAC K CHARLES | President and CEO | SELL | 9,000 | $14.66 | $132.0K |
| Mar 10, 2026 | Bayview Legacy, LLC | 10%+ Owner | SELL | 9,000 | $14.66 | $132.0K |
| Mar 9, 2026 | JANAC K CHARLES | President and CEO | SELL | 41,000 | $14.21 | $582.6K |
| Mar 9, 2026 | Bayview Legacy, LLC | 10%+ Owner | SELL | 41,000 | $14.21 | $582.6K |
| Mar 4, 2026 | RAZA SAIYED ATIQ | Director | SELL | 3,690 | $17.02 | $62.8K |
| Mar 2, 2026 | RAZA SAIYED ATIQ | Director | SELL | 106,031 | $17.21 | $1.8M |
| Feb 27, 2026 | RAZA SAIYED ATIQ | Director | SELL | 11,762 | $17.01 | $200.0K |
| Feb 26, 2026 | RAZA SAIYED ATIQ | Director | SELL | 73,610 | $17.14 | $1.3M |
| Feb 25, 2026 | RAZA SAIYED ATIQ | Director | SELL | 4,907 | $17.00 | $83.4K |
| Feb 20, 2026 | JANAC K CHARLES | President and CEO | G | 70,000 | $0.00 | $0.00 |
| Feb 20, 2026 | Bayview Legacy, LLC | 10%+ Owner | G | 70,000 | $0.00 | $0.00 |
| Feb 18, 2026 | Moll Laurent R | Chief Operating Officer | A | 37,553 | $0.00 | $0.00 |
| Feb 18, 2026 | Hawkins Nicholas B. | VP and Chief Financial Officer | A | 41,217 | $0.00 | $0.00 |
| Feb 18, 2026 | Alpern Paul L | VP and General Counsel | A | 32,385 | $0.00 | $0.00 |
| Feb 18, 2026 | JANAC K CHARLES | President and CEO | A | 78,051 | $0.00 | $0.00 |
14 SEC filing reports analyzed. Sentiment: 1 bullish, 4 bearish, 1 mixed, 8 neutral. Avg impact: 4.4/10.
NEUTRAL
CLUSTER
4/10
Two insiders at Arteris sold a total of $2.51M in open-market sales within a week of the company's s
May 20, 2026
NEUTRAL
CLUSTER
4/10
Insiders at Arteris, including CEO and CFO, sold a total of $6.87M in shares over the past week, fol
May 16, 2026
BEARISH
144
5/10
Nicholas B. Hawkins, an officer of Arteris, filed a Form 144 to sell 221,035 shares of common stock
May 15, 2026
NEUTRAL
CLUSTER
4/10
Three insiders at Arteris, including the CEO and a director, sold a total of $4.90M in shares over a
May 14, 2026
MIXED
CLUSTER
5/10
Three Arteris insiders sold a total of $2.94M in open-market sales within days of the company report
May 12, 2026
BULLISH
8-K
7/10
Arteris reported Q1 2026 revenue of $22.9M (+39% YoY), beating consensus of $21.0M, and a GAAP net l
May 12, 2026
NEUTRAL
CLUSTER
3/10
Two directors at Arteris sold a combined $752K in open-market sales over a 7-day window, representin
May 7, 2026
NEUTRAL
PRESS-RELEASE
3/10
Arteris announced it will release Q1 2026 financial results on May 12, 2026, after market close, fol
Apr 22, 2026
NEUTRAL
DEFA14A
3/10
Arteris, Inc. filed a definitive proxy statement for its 2026 annual shareholder meeting, proposing
Apr 21, 2026
BEARISH
CLUSTER
5/10
Three insiders at Arteris, Inc. (AIP) sold shares over a 7-day period, including a Chief Operating O
Apr 21, 2026
NEUTRAL
144
3/10
S. Atiq Raza, a director of Arteris, Inc., filed a Form 144 to notify intent to sell up to 90,000 sh
Apr 17, 2026
BEARISH
CLUSTER
7/10
Arteris CEO and COO, along with a 10% shareholder, sold over $2.69 million in shares within a 7-day
Apr 14, 2026
NEUTRAL
CLUSTER
3/10
Multiple corporate insiders at Arteris, Inc. conducted open-market share sales over a 7-day period,
Apr 7, 2026
BEARISH
CLUSTER
6/10
Arteris CEO Charles Janac and affiliated entity Bayview Legacy, LLC collectively sold 40,000 shares
Mar 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (75% buy). Based on 8 analysts: 1 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$37.75 mean target
+7.0% upside
Buy (1.50)
$35.00 Low
$40.00 High
| Metric | Value |
|---|---|
| Current Price | $35.28 |
| Target Low | $35.00 |
| Target Mean | $37.75 |
| Target Median | $38.00 |
| Target High | $40.00 |
| # Analysts | 4 |
| Recommendation | Buy (1.50) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.04 | $-0.05 | $-0.03 | 65.9% | — | 2↑ 0↓ | $0.0B | 42.4% | 4 |
| Next Q 2026-09-30 |
$-0.02 | $-0.03 | $-0.02 | 75.0% | — | 1↑ 1↓ | $0.0B | 34.4% | 4 |
| Current FY 2026-12-31 |
$-0.09 | $-0.10 | $-0.07 | 73.5% | — | 2↑ 0↓ | $0.1B | 33.3% | 4 |
| Next FY 2027-12-31 |
$0.16 | $0.13 | $0.20 | 282.9% | — | 1↑ 0↓ | $0.1B | 20.3% | 3 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.037 | |
| 7d ago | $0.000 | -0.037 |
| 30d ago | $0.000 | -0.037 |
| 60d ago | $-0.055 | +0.018 |
| 90d ago | $-0.048 | +0.010 |
3 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 13, 2026 | Jefferies | MAINTAIN | Hold | Hold |
| May 13, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| May 13, 2026 | Rosenblatt | MAINTAIN | Buy | Buy |
| Feb 13, 2026 | Rosenblatt | MAINTAIN | Buy | Buy |
| Dec 15, 2025 | Rosenblatt | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 1 | 5 | 2 | 0 | 0 | 75% | |
| Apr 1, 2026 | 1 | 5 | 2 | 0 | 0 | 75% | |
| Mar 1, 2026 | 1 | 5 | 2 | 0 | 0 | 75% | |
| Feb 1, 2026 | 1 | 5 | 2 | 0 | 0 | 75% | |
| Jan 1, 2026 | 1 | 5 | 2 | 0 | 0 | 75% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
50°
Neutral
Bearish
Neutral
Bullish
10 mentions
3 bullish
3 bearish
10 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 11, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 11, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Apr 15, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 28, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Mar 28, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Mar 12, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Mar 12, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Mar 6, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 6, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Feb 19, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
Recent Reddit Threads
May 20, 2026
other
Arteris Technology Adopted by Li Auto for Intelligent Vehicles
Arteris technology adopted by Li Auto for intelligent vehicles, starting with its proprietary SoCs used in the all-new L9 Livis high-tech SUV.
May 12, 2026
earnings_calendar
AIP Q1 2026 Earnings Scheduled — 2026-05-12
Apr 30, 2026
other
Arteris Wins Stevie Award for Technology Innovation of the Year
Arteris wins Stevie® Award for 2026 Technology Innovation of the Year, honoring its semiconductor cybersecurity assurance technology.
Apr 30, 2026
earnings_calendar
AIP Q1 2026 Earnings Scheduled — 2026-04-30
Apr 27, 2026
short_interest
FTD: AIP — 35,610 shares ($1.0M) failed to deliver
Settlement: 20260427, Price: $26.72, FTD Value: $951,499.2, ARTERIS INC COM (DE)
Apr 22, 2026
earnings
Arteris to Announce Financial Results for the First Quarter 2026 on Tuesday, May 12, 2026
<p align="left">CAMPBELL, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for
Mar 25, 2026
other
Arteris Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
Arteris had been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2026.
Mar 4, 2026
other
Arteris Network-on-Chip Technology Achieves Deployment Milestone of 4 Billion Chips and Chiplets Globally
Arteris network-on-chip technology achieves deployment milestone of 4 billion chips and chiplets globally.